Edition:
United States

Immune Design Corp (IMDZ.OQ)

IMDZ.OQ on NASDAQ Stock Exchange Global Market

1.41USD
18 Dec 2018
Change (% chg)

-- (--)
Prev Close
$1.41
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
92,029
52-wk High
$5.03
52-wk Low
$1.26

Chart for

About

Immune Design Corp. is a clinical-stage immunotherapy company. The Company is focused on cancer with in vivo approaches designed to enable the body's immune system to fight disease. The Company has engineered its technologies to activate the immune system's natural ability to create tumor-specific cytotoxic T cells (CTLs) to... (more)

Overall

Beta: 2.53
Market Cap(Mil.): $65.50
Shares Outstanding(Mil.): 48.16
Dividend: --
Yield (%): --

Financials

  IMDZ.OQ Industry Sector
P/E (TTM): -- 95.96 30.88
EPS (TTM): -1.14 -- --
ROI: -63.53 0.60 13.80
ROE: -63.61 -2.18 15.29

Earnings vs. Estimates